I’m hiring a Research Technician and a Computational Postdoc! 💻 Computational Postdoc to model context-dependent protein interactions: open until 15th of June: www.werkenbijavl.nl/vacatures/co... 🔬 Technician: open until 3rd of June: www.werkenbijavl.nl/vacatures/re... Please share! #ScienceJobs

Computational Postdoc | Werken bij AVL

Computational postdoc in the Lindeboom lab to study context-dependent protein interactions The Lindeboom lab is looking for a talented and motivated ERC-funded computational postdoc who is interested...

werkenbijavl.nl

I am deeply honoured to be awarded the NVBMB Prize 2026! I feel very grateful for this recognition, and especially for the many colleagues, mentors, and team members who have supported me scientifically and helped me get to this point. A big thank you to the NVBMB for this award.

The 2026 NVBMB prize has been awarded to Dr. Rik Lindeboom, Netherlands Cancer Institute (NKI) in Amsterdam

The jury of the NVBMB prize was unanimous in its advice to award the 2026 prize to Dr. Rik Lindeboom from the Netherlands Cancer Institute (NKI). Rik has already made several seminal achievements and ...

nvbmb.kncv.nl

Congratulations to Rik Lindeboom on receiving the 2026 NVBMB Prize 🎉 The jury unanimously recognized Rik as a rising star in biochemistry & molecular biology, praising seminal contributions, bold high-impact research, exceptional productivity, and a strong commitment to open tools for the community

Join us! Postdoc opening in proteomics & immunotherapy: a Voest/vdHaar-Lindeboom lab collaboration at NKI.

Joris van de Haar, MD, PhD@joris-vd-haar.bsky.social · 9mo ago

🚀 We’re hiring! Join our team at the NKI as a Postdoc, using Quantitative Membrane Proteomics to design novel cancer immunotherapies! Best of two worlds from the Voest and Lindeboom Labs. Cutting-edge proteomics, translational immunotherapy and world-class instrumentation? let’s connect! 🔬💡

Preprint alert! 🚨 Presenting MHC1-TIP: a scalable, cost-effective workflow for MHC-I ligandome + proteome profiling from diverse samples, to for example uncover intratumoral heterogeneity in RCC. Spearheaded by Mayukha Bathini, and big thanks to all collaborators! biorxiv.org/content/10.1...

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation

Profiling antigens presented on MHC class I molecules on the cell surface is essential to identify candidate antigens for targeted and personalized immunotherapies. However, mass spectrometry-based im...

biorxiv.org

Are you a group leader within the research field Chemistry of Life? Would you like to strengthen your network? Then join us at the Chemistry of Life community day 2025 on 17 April @tudelfttnw.bsky.social Register 👇 www.nwo.nl/en/meetings/... deadline: 10 April

Grateful to have received the ZonMW Open Competition grant together with @chirlmin.bsky.social. We will combine molecular engineering, single-molecule imaging, and genomics to investigate the binding kinetics of antigens to MHC class II and T cell receptors. Exciting times ahead!

Excited to share that our single-cell proteomics workflows at @nkinl.bsky.social just got a major upgrade with the installation of the cellenONE single-cell isolation robot! This tech will help us push the boundaries of proteomics in cancer, one cell at a time.

We're proud to participate with top labs in this prestigious PhD program. There's less than a month left to apply, don't miss this opportunity!

Netherlands Cancer Institute @nkinl.bsky.social · 2y ago

Are you graduating this year and ready to start your career in the most meaningful way? This is your chance to get on board. #PhD #CancerResearch ➡️ nki.nl/careers-study/phd-students/nki-phd-program-2025/

I'm incredibly grateful to have received the Young Investigator Grant from KWF and Alpe d'HuZes! This grant will support our work on understanding how antigen presentation dynamics are regulated and how these processes occur in penile cancers.

39 miljoen voor nieuw onderzoek en medicijnontwikkeling

KWF investeert 39 miljoen euro in nieuw kankeronderzoek, waarvan 11 miljoen bestemd is voor academische geneesmiddelontwikkeling.

kwf.nl

The #Proteomics Facility at The Netherlands Cancer Institute is seeking to expand its team with a #technician! This is an exciting opportunity to contribute to cutting-edge clinical and cell biology projects using state-of-the-art proteomics technologies. Share or apply via the link below.

Exciting news for aspiring #PhD students: the NKI PhD Program 2025 will open soon for applications! We participate with multiple top labs in this prestigious program, which offers a unique opportunity for PhD candidates to engage in cutting-edge genome biology and cancer research. #Science

Netherlands Cancer Institute @nkinl.bsky.social · 2y ago

📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info: bit.ly/3O4bOjq